Articles tagged with Disease Progression
The American Heart Association has awarded $15 million to researchers studying the role of inflammation in cardiac and brain diseases. The four-year project aims to better understand the body's response to inflammation and prevent or treat inflammation-driven cardiovascular diseases.
The Kidney-CHAMP study found that the intervention helped primary care physicians identify and triage patients with kidney disease, improving patient access to specialists and educational materials. Despite a null result, the study's findings suggest that the framework is scalable and provides equitable access to healthcare.
Researchers at Nagoya University discover aldehydes cause DNA damage and contribute to premature aging in humans. The team proposes a link between aldehyde-derived DNA damage and premature aging, highlighting potential targets for therapeutic intervention.
Researchers found that CMS121 reduced body weight gain by 40% and improved glucose and lipid indexes in aging mice. The compound also showed anti-inflammatory effects and increased mitochondrial biogenesis, suggesting potential therapeutic applications for metabolic diseases.
A study published in JCI Insight reveals that an unexpected mechanism is responsible for the loss of kidney cells' ability to filter toxins from blood in primary membranous nephropathy. The researchers found that signaling in the C3a/C3aR pathway plays a critical role in disease progression.
The study found that reductions in deaths from chronic respiratory diseases, stroke, lower respiratory infections, and cancer led to the largest net gain in life expectancy between 1990 and 2021. The super-region of Southeast Asia, East Asia, and Oceania had the largest net gain, while South Asia had the second-largest increase primari...
Long-term treatment with methylene blue (MB) and mitoquinone (MitoQ) did not alter age-related bone loss in mice. Antioxidant interventions are insufficient to inhibit skeletal aging, suggesting alternative approaches may be needed.
University of Virginia researchers have identified a single gene on the Y chromosome that can account for the disease-promoting effects of Y chromosome loss. This discovery provides new avenues for understanding the causes of heart disease and could lead to a treatment for men with Y chromosome loss.
Researchers assessed the feasibility of dual PD-L1/CTLA-4 checkpoint inhibition in Stage II or III hormone receptor-positive, HER2-negative breast cancer. Eight patients received upfront durvalumab and tremelimumab prior to neoadjuvant chemotherapy, showing mixed responses and limited benefit.
Researchers are developing a flexible online tool to navigate information used in the fight against deadly diarrheal diseases. The Plan-EO dashboard will provide real-time data on pathogen dynamics, allowing infectious disease experts and local leaders to make smart decisions and save lives.
Researchers have discovered that PR55α, a regulatory subunit of PP2A phosphatase, inhibits p16 expression and blocks cellular senescence induction by γ-irradiation. This finding provides a new insight into the regulation of the p16/RB pathway in response to stressors.
A Johns Hopkins Medicine-led team has developed a fluid biomarker that can detect the early stages of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The biomarker, HDGFL2, is associated with TDP-43 function loss and can be detected in blood or cerebrospinal fluid samples.
Researchers have identified a genetic variant in SIRPβ1 gene that affects the immune system's response to beta-amyloid deposits, leading to altered Alzheimer's disease progression. The mutation has been shown to increase cognitive decline in early stages but slow it down in advanced stages.
Researchers used generative AI to design a lead molecule for treating fibrosis, a biological process associated with aging. The compound, INS018_055, demonstrated significant efficacy in preclinical studies and showed promising results in clinical trials, accelerating drug discovery and providing new therapeutic options.
The study found that Mancozeb exposure leads to increased reactive oxygen species, redox imbalance, and liver biomarker elevation. XBP1s and NOX4 gene expression is also upregulated in response to MZ toxicity, indicating potential for early bio-indicators of endoplasmic reticulum stress.
Researchers define a 'core senescent profile' in human colon fibroblasts, revealing potential driver proteins involved in CRC. The study's findings provide insights into therapies for improving overall health and preventing CRC.
Researchers created Elenagen, a novel DNA immunotherapy for deadly ovarian cancer, which significantly enhances standard chemotherapy and provides clinical benefits. The study shows that Elenagen delays disease progression in patients with stage III and IV platinum-resistant ovarian cancer.
A UNLV-led research team has made groundbreaking discoveries about how cells detect and destroy disease-causing proteins using complex nanomachines called cullin-RING ligases. The findings may accelerate drug discovery studies and provide insights into human disease.
A new nanocomposite porous antifouling coating has been developed, enabling higher numbers of biomarker-detecting probes and up to 17-fold higher sensitivities than previous best-in-class sensors. This breakthrough broadens the diagnostic horizon for multiplexed electrochemical sensors across multiple diseases.
The PsyPal study will investigate psilocybin therapy's effectiveness in easing psychological distress in patients with incurable diseases. The trial aims to treat over 100 patients across four clinical sites, using a combination of psychotherapy and pharmacotherapy.
A new study reveals that RNA binding motif protein X-linked (RBMX) plays a crucial role in predicting cancer prognosis and response to immunotherapy. Abnormal expression of RBMX is associated with immune regulation, tumor microenvironment, and therapeutic effects of immune checkpoint inhibitors.
A new research effort, led by University of Oklahoma's Zhibo Yang and San Diego State University's Laura-Isobel McCall, aims to investigate the role of bystander cells in infectious diseases. By examining metabolism changes in non-infected cells near infected cells, researchers hope to gain insights into possible disease progression.
The American Heart Association has made significant medical advancements over the past 100 years, including the development of artificial heart valves and implantable pacemakers. The organization continues to work towards health equity, with a focus on removing barriers to healthcare for diverse populations.
A team of researchers discovered a multiprotein complex involving NLRP3, AIM2, NLRC4, and Pyrin that drives PANoptosis, a type of programmed inflammatory cell death. The findings have implications for understanding inflammasome biology and identifying potential therapeutic targets.
Researchers develop a versatile imaging system for targeted spectroscopy in the eye fundus, allowing for continuous color imaging and spectral measurements. The system enables users to select targets and move them to any location within the eye fundus region without realignment or fixation changes.
Researchers at IRB Barcelona discover iron accumulation as a driver of pathological senescence and fibrosis, highlighting its role in various fibrotic disorders. The study identifies potential methods for non-invasive assessment and treatment of fibrotic diseases via MRI and chemical compounds.
Researchers found lower levels of serotonin transporter and higher levels of amyloid-beta protein in brains of people with mild cognitive impairment, a potential target for treatments to slow or stop disease progression. Further research is needed to study the role of serotonin in disease progression.
Researchers at the University of Turku found that bexmarilimab therapy alters macrophage behavior to promote anti-tumor immune defense. The therapy was well-tolerated and stabilized disease progression in patients with advanced-stage cancer, inducing tumor-associated macrophage and lymphocyte activation.
A new Stanford Medicine-led study reveals that organs age at different rates, and when an organ's age is advanced, individuals are at heightened risk for diseases. The study found that nearly 1 in 5 healthy adults over 50 have at least one organ aging rapidly, guiding therapeutic interventions before clinical symptoms manifest.
A world-first human trial shows that a commonly prescribed rheumatoid arthritis drug can safely and effectively preserve the body's own insulin production and suppress the progression of type 1 diabetes. The drug, baricitinib, was found to be effective in maintaining insulin production in people who initiated treatment within 100 days ...
Researchers found that treating C. elegans with mitochondrial inhibitors extended their lifespan, improved pharyngeal muscle contraction, reduced lipofuscin content, and decreased energy consumption. The study suggests that these drugs could abrogate aging and extend human lifespan, offering a potential therapeutic approach.
The C-Path Neuroscience Annual Workshop brought together stakeholders to chart a transformative course for neurology research and drug development, focusing on chronic progressive diseases such as Alzheimer's and Parkinson's. Key highlights included recommendations for innovative therapies and tools to address complex disorders.
Researchers found that patients with elevated NfL levels had a 91% higher risk of worsening disability with relapse within a year, and a 49% higher risk without relapse nearly two years later. The study suggests that interventions may prevent worsening symptoms by targeting nerve cell death.
Researchers describe the use of ripretinib and repeated surgical resection in a patient with recurrent GIST harboring a KIT exon 11 mutation. The treatment led to extended clinical benefit, outperforming current reported data from ripretinib clinical trials.
A UCLA-led study shows datopotamab deruxtecan, a Trop-2 directed antibody-drug conjugate, significantly improves progression-free survival in patients with metastatic non-small cell lung cancer. The treatment primarily benefits patients with non-squamous tumors, reducing disease progression and improving overall survival.
A new study reveals that autophagy plays a crucial role in the gradual loss of DNA content in diploid Saccharomyces cerevisiae cells undergoing chronological aging. The researchers found that only diploids survived, and autophagy induction was responsible for the DNA loss.
Engineers use module assembly to develop vascularized organotypic tissues with high cell density and well-organized vasculature. This approach enables the rapid generation of functional tissue substitutes with improved efficacy in treating diseases.
A team of researchers has created a 'proteomic clock' that can predict a healthy person's age based on their protein profile, revealing accelerated aging due to diseases. The study also detected proteins associated with Parkinson's disease in eye fluid, offering a potential pathway for earlier diagnoses.
Scientists have developed a technique to restore the function of human-derived GPCR proteins in yeast cells, which could accelerate research and lead to more effective treatments. The approach, using error-prone polymerase chain reaction, introduces random mutations that enhance protein stability and function.
A new trial combining an Alzheimer's medication with two other drugs may amplify its effects and arrest disease progression. The trial, funded by a $150M grant, will recruit 900 participants with early-onset Alzheimer's.
Researchers at Queen Mary University of London developed a new organ-on-a-chip model of the human synovium to study arthritis mechanisms and develop new treatments. The three-dimensional microfluidic device successfully replicates key features of native synovium biology.
Researchers assembled an atlas of hundreds of cell types that make up a human brain in unprecedented detail. The study uses techniques originally developed for mice to identify brain cell subtypes in human brains.
Researchers developed an AI tool that can detect valvular heart disease with 93% sensitivity and 98% specificity. The tool analyzes audio data from a short burst of sound vibrations using a contact microphone and neural networks, allowing for quick identification of five different valvular diseases.
Post-Acute Sequelae of COVID-19 research aims to track long-term health symptoms in survivors. A $3.7 million grant will support the development of self-supervised deep learning technologies to recognize post-COVID lung progression phenotypes.
Researchers developed three new two-photon probes that can visualize organelles in cells, enabling better understanding of cellular functions and tissue imaging. The probes are designed to detect pH levels, viscosity, and ionic species, providing more specific insights into cell viability and treatment responses.
Researchers at the University of Birmingham found that individuals with fatty liver disease are three times more likely to have a personality disorder than those without. Lifestyle modifications, such as changes in diet and exercise, can prevent disease progression but often fail to be implemented due to mental health factors.
Researchers have discovered a peptide that stabilizes the normal structure of alpha-synuclein protein, preventing misfolding and toxic clumps. This breakthrough could lead to new therapeutic developments for neurodegenerative diseases like Parkinson's.
A phase 3 trial found that an internet-delivered cognitive behavioral therapy program significantly reduced depressive symptoms in patients with multiple sclerosis. The online program, modified for MS, led to a large drop in depressive symptoms compared to a control group.
A new study from the University of British Columbia suggests that people with multiple sclerosis are nearly twice as likely to experience mental illness before symptoms appear. The research found higher rates of psychiatric conditions in patients with MS compared to the general population.
Researchers developed a DNA damage-induced senescence model in osteoarthritic chondrocytes, which reliably induces cellular senescence and accumulates senescent cells in OA joint tissues. The study provides a useful model to develop therapeutic approaches targeting senescence in osteoarthritis.
Researchers have characterised a specialised type of immune cell that plays a key role in protecting and repairing the healthy human gut. Depletion of these cells is linked to inflammatory bowel disease (IBD) progression, with potential implications for treatment options.
A study of nearly 20,000 patients found that the color of their phlegm can indicate the degree of inflammation in their lungs and predict future outcomes. Patients with darker green or brown-colored sputum were at a higher risk of exacerbations, hospitalizations, and death.
A Penn State research team proposes a new information-filtering approach to predict future health information needs of online community participants. The approach incorporates user profiles, past posts and replies to categorize online content and provide more personalized healthcare resources.
Researchers found that C9ORF72 mutations impair neural stem cell renewal, leading to reduced brain regions during embryonic development. This impairment could contribute to disease symptoms later in life. The study used patient-derived nerve cells and laboratory mice to demonstrate the impact of C9ORF72 on neurodevelopment.
An intensive lifestyle intervention was associated with increased employment rates and improved labor market outcomes. The study suggests that such interventions can positively impact individuals with type 2 diabetes, highlighting the importance of considering labor market productivity in disease management.
Researchers propose disease-oriented dosing of rapamycin to delay age-related diseases and increase lifespan. By decelerating early development of these diseases, rapamycin may help individuals live longer.
Researchers found that human senescent fibroblasts trigger progressive lung fibrosis in immunodeficient mice by inducing paracrine senescence and pro-fibrotic activities. The study also suggests that senolytic compounds like navitoclax can ameliorate lung fibrosis induced by senescent human fibroblasts.
Researchers found that Alzheimer's patients exhibit heightened sensitivity to light changes, which can contribute to 'sundowning' and disease progression. Light therapy could help manage these symptoms and potentially slow disease progression.
Researchers have found that gut health is the main determinant of systemic inflammation and disease progression in HIV. By targeting the root cause of problems, therapies may be able to slow the progression of the virus by preserving gut integrity.
Researchers at the University of Copenhagen have discovered a way to replace diseased and aged brain cells with new ones, which could lead to treatments for neurodegenerative diseases like Huntington's disease and multiple sclerosis. The study used humanized mice models to test the effectiveness of glial cell transplantation.